Cemiplimab combined with chemotherapy versus chemotherapy in advanced non-small cell lung cancer: an updated EMPOWER-Lung 3 trial-based cost-effectiveness analysis

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10666692 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature